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Abstract: Heat-stable enterotoxins are the most notable virulence factors associated with 
Staphylococcus  aureus,  a  common  pathogen  associated  with  serious  community  and 
hospital  acquired  diseases.  Staphylococcal  enterotoxins  (SEs)  cause  toxic  shock-like 
syndromes and have been implicated in food poisoning. But SEs also act as superantigens 
that stimulate T-cell proliferation, and a high correlation between these activities has been 
detected. Most of the nosocomial S. aureus infections are caused by methicillin-resistant 
S. aureus (MRSA)  strains,  and  those  resistant  to  quinolones  or  multiresistant  to  other 
antibiotics are emerging, leaving a limited choice for their control. This review focuses on 
these  diverse  roles  of  SE,  their  possible  correlations  and  the  influence  in  disease 
progression and therapy. 
Keywords: enterotoxins; Staphylococcus aureus; superantigens; MRSA; immune response 
 
1. Introduction 
Staphylococcus  aureus  is  a  common  pathogen  associated  with  serious  community  and  hospital 
acquired diseases and has for a long time been considered as a major problem of Public Health [1]. 
Furthermore, S. aureus is often present in foods [2,3] and it is among the leading causes of foodborne 
bacterial intoxications worldwide [4–6]. Several virulence factors implicated in the pathogenesis of 
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S. aureus strains have been described previously such as thermonuclease, hyaluronidase, lipases and 
hemolysisn [7–9], which are involved in tissue invasion of the host. Perhaps the most notable virulence 
factors associated with this microorganism are the heat-stable enterotoxins that cause the sporadic 
food-poisoning syndrome or foodborne outbreaks [10,11]. 
Staphylococcal enterotoxins (SEs) belong to a large family of staphylococcal and streptococcal 
pyrogenic  exotoxins  (PT),  sharing  common  phylogenetic  relationships,  structure,  function,  and 
sequence homology. These toxins cause toxic shock-like syndromes and have been implicated in food 
poisoning  and  several  allergic  and  autoimmune  diseases.  Included  within  this  group  are  the 
staphylococcal  enterotoxins,  two  forms  of  toxic  shock  syndrome  toxin  (TSST),  and  a  group  of 
streptococci pyrogenic exotoxins [12]. 
SEs  function  not  only  as  potent  gastrointestinal  toxins  but  also  as  superantigens  that  stimulate 
non-specific  T-cell  proliferation.  Although  these  are  two  separate  functions  localized  on  separate 
domains of the proteins, there is a high correlation between these activities and in most cases a loss of 
superantigen activity (because of a genetic mutation) results in loss of enterotoxic activity as well [13]. 
Antimicrobial resistance is also an important public health concern worldwide. The development of 
resistance  both  in  human  and  animal  bacterial  pathogens  has  been  associated  with  the  extensive 
therapeutic use of antimicrobials or with their administration as growth promoters in food animal 
production  [14,15].  Apart  from  having  pathogenic  versatility,  S.  aureus  can  adapt  rapidly  to  the 
selective  pressure  of  antibiotics,  with  the  emergence  and  spread  of  methicillin-resistant  S.  aureus 
(MRSA) isolates being a relevant example. MRSA was first described in 1961, the year in which 
methicillin was marketed [16], and actually most of the nosocomial S. aureus infections are caused by 
methicillin-resistant S. aureus strains [17], which have become a widely recognized cause of morbidity 
and  mortality  throughout  the  world  [1,18,19].  S.  aureus  becomes  methicillin  resistant  by  the 
acquisition of the mecA gene which encodes a penicillin binding protein (PBP2a) with a low affinity 
for β-lactams. The strains producing PBP2a are resistant to all β-lactams [20]. Thus, MRSA strains 
resistant to quinolones or multiresistant to other antibiotics have been emerging, leaving a limited 
choice for their control [21,22].  
2. Diversity of Staphylococcus aureus Enterotoxins 
The first well-documented report, which clearly identified a Staphylococcus aureus toxin as the 
cause of food poisoning outbreaks, was done by Dack et al. [23]. They isolated a pigment-forming 
Staphylococcus  present  in  large  numbers  in  a  Christmas  cake  responsible  for  a  food  poisoning 
incident, and sterile filtrate from a broth, in which the organism was grown, produced illness when 
ingested by human volunteers. Initially, five antigenic variants of S. aureus enterotoxins designated 
SEA through SEE were identified and reported in the literature [24–28]. Since then, new variants have 
been identified and designated SEH to SElR, and SElU in the order that they were discovered [29]. 
These  staphylococcal superantigenic  toxins  can  be  divided  into three large groups and one minor 
group on the basis of similarity of amino acid sequences. Most toxins of the three groups, including 
staphylococcal enterotoxins A and B (SEA and SEB), exhibit strong emetic activity in primates; toxic 
shock syndrome toxin-1, grouped as the minor group, does not possess emetic activity in primates. It is 
noteworthy that toxins designated SE-like toxins, such as SElP, which either have not been examined Toxins 2010, 2                                 
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for emetic activity or have been reported not to have emetic activity, have been discovered in S. aureus 
strains [30]. Recently, two novel staphylococcal enterotoxins, types S and T have been identified and 
characterized, and SElR has been shown to possess emetic properties, so it should be designated SER 
from now on [31]. 
Enterotoxins are short secreted proteins, soluble in water and saline solutions. They share common 
biochemical and structural properties and are remarkably resistant to heat: the potency of these toxins 
can only be gradually decreased by prolonged boiling or autoclaving. Excepting toxic shock syndrome 
toxin-1 (TSST-1), they are highly stable and resistant to most proteolytic enzymes, and thus retain 
their activity in the digestive tract after ingestion [32]. Their biological properties include induction of 
high fever similar to bacterial endotoxin induction, lethal shock in animals resulting from excessive 
intravenous  doses,  enhanced  host  susceptibility  to  endotoxin  lethality,  cytokine  production,  and 
polyclonal T-lymphocyte proliferation as seen with superantigens (SAgs)[33,34]. 
As to the SE production and regulation, S. aureus has developed overlapping subsets of accessory 
genes dedicated to regulating the expression of other genes, including SEs and TSST-1.The most 
well-known and predominant regulon in S. aureus is the agr system (accessory gene regulator). It is a 
quorum-sensing system activated at high cell density. In vitro, upon activation, agr downregulates the 
expression of genes encoding surface proteins and upregulates genes encoding exoproteins, such as 
SEB, SEC, SED and TSST-1 [35,36]. However, this is not the global rule for SE expression because 
SEA is constitutively expressed by S. aureus while SEG and SEI were initially thought to be produced 
only at low bacterial concentrations [37]. Until now the question of SEG and SEI production seems to 
be controversial, as there is no evidence confirming this [38,39]. Indirect evidence indicates only that 
its expression can be triggered by environmental factors [40,41].  
Arginine  and  cystine  are  also  necessary  for  both  growth  and  SE  production  in  five  strains  of 
S. aureus that produce SEA, SEB or SEC, while the necessities for other aminoacids vary with the 
strain [42]. On the contrary, glucose has been shown to have an inhibitory effect on SE production, 
especially for SEB and SEC [43]. This inhibitory effect has been attributed to a drop in pH, as a 
consequence of glucose metabolism. These observations could also be correlated with agr-dependent 
synthesis of these SEs, as glucose and low pH indeed have an inhibitory effect on agr-expression [35]. 
3. Pathogenicity of SE 
Staphylococcus aureus is an unusually successful and adaptive human pathogen that can cause 
epidemics of invasive disease despite its frequent carriage as a commensal. Over the past 100 years 
and more, S. aureus has caused cycles of outbreaks in hospitals and the community and has developed 
resistance to every antibiotic used against it, yet the exact mechanisms leading to epidemics of virulent 
disease are not fully understood. This microorganism is a versatile pathogen capable of causing a wide 
range  of  human  diseases  due  to  a  combination  of  toxin-mediated  virulence,  invasiveness,  and 
antibiotic resistance. The spectrum of staphylococcal infections ranges from pimples and furuncles to 
toxic shock syndrome and sepsis, most of which depend on numerous virulence factors. On the other 
hand, some infections, such as staphylococcal food poisoning, rely on one single type of virulence 
factor: the SEs.  Toxins 2010, 2                                 
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3.1. Staphylococcal Food Poisoning 
Many different foods can be a good growth medium for S. aureus, and have been implicated in 
staphylococcal food poisoning, including milk and cream, cream-filled pastries, butter, ham, cheeses, 
sausages, canned meat, salads, cooked meals and sandwich fillings. The origins of staphylococcal food 
poisoning differ widely among countries and this may be due to differences in the consumption and 
food habits  in  each of the countries.  In  any  case,  the main sources of contamination are humans 
(handlers contaminate food via manual contact or via the respiratory tract by coughing and sneezing), 
and contamination occurs after heat treatment of the food. Nevertheless, in food such as raw meat, 
sausages, raw milk, and raw milk cheese, contaminations from animal origins are more frequent and 
due to animal carriage or to infections (e.g., mastitis)[44]. 
The  symptoms  of  staphylococcal  food  poisoning  are  abdominal  cramps,  nausea,  vomiting, 
sometimes followed by diarrhea after a short period of incubation [44]. In contrast to the well-known 
clinical  manifestations,  the  physiopathology  of  the  symptoms  is  only  partially  understood. 
Gastroscopic examination of patients with acute SE intoxication show gastrointestinal damage with 
patchy  mucosal  hyperemia,  regional  edema,  muscular  irritation,  erosion,  petechiae  and  purulent 
exudates  [45].  In  these  areas,  an  influx  of  polymorphonuclear  cells  into  the  lamina  propria  and 
epithelium  can  be  observed.  SEs  can  penetrate  the  gut  lining  and  gain  access  to  both  local  and 
systemic immune tissues. It has been postulated that local immune system activation by SEs could be 
responsible for the gastrointestinal damage observed as well as mast cell activation. The release of 
inflammatory mediators (histamine and leukotriene) and neuroenteric peptide substance P upon SE 
activation could also be responsible for the gastrointestinal tract damage [46]. Histamine release is also 
associated with other types of food poisoning, but the question still remains as to whether synthesis of 
these mediators is induced directly or indirectly by SEs. Diarrhea in staphylococcal food poisoning 
may be due to the inhibition of water and electrolyte reabsorption in the small intestine by SEs as 
observed both in vitro and in an animal model. Emetic activities of SEs and related toxins are not 
equivalent. TSST-1 is not emetic, probably due to its sensitivity to digestive tract enzymes. Other SEs 
such  as  SEI  and  SElL  are  either  weak  or  not  emetic;  these  two  toxins  lack  the  disulfide  bond 
characteristically  at  the  top  of  domain  B,  which  may  stabilize  a  crucial  conformation  within  or 
adjacent to the loop probably important for emesis activity [47]. Studies involving mutations in various 
SEs show no link between reduction on T cell proliferation and emesis [13,48], although studies that 
dissociate monocyte activation from emesis are still lacking.  
3.2. Toxic Shock Syndrome (TSS) 
First reported by Todd [49], TSS is a major systemic illness associated with acute intoxication with 
TSST-1  and  SEs.  It  is  characterized  by  an  acute  onset  of  high  fever,  diffuse  erythematous  rash, 
desquamation of the skin, hypotension, and the involvement of three or more organ system failures. 
The  TSS  pathophysiology  model  involves  a  capillary  leak  syndrome  stemming  from  toxin-  and 
cytokine-mediated  endothelium  damage.  In  vitro,  SAgs  as  well  as  proinflammatory  cytokines  are 
lethal for endothelial cells [50]. Regarding the respective roles of monocytes and T lymphocytes in the 
host inflammatory response to SAgs, the literature remains controversial. Dinges et al. [51] showed  
T-independent mortality induced by TSST-1 in a rabbit model. SEB induced the production of TNF- Toxins 2010, 2                                 
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by  isolated  monocytes  but  not  by  nonmonocytes  or  purified  T  cells,  suggesting  that  the 
proinflammatory reaction can occur without the presence of T cells. On monocytes, SAgs interact 
mainly with MHC class II. SEA, SED and SEE possess a cysteine domain involved in high-affinity 
binding to MHC class II that is absent in SEB, SEC and TSST-1 [52], so it has been hypothesized that 
differences in SAgs inflammatory properties could be a reflection of respective differences in their 
MHC class II binding properties. Wright and Chapes [53] proposed another mechanism of action for 
SAgs on monocytes.  They have  demonstrated that  SEA could also interact with MHC class I on 
monocytic cells deficient for MHC class II and induce an important cytokine response, most notably 
the release of TNF- and IL-6. On the other hand, several reports proposed a predominant role for  
T-lymphocytes  in  inducing  the  inflammatory  response.  Marrack  et  al.  [54]  showed  that  the 
pathological effect of SEB may be the consequence of massive T cell stimulation. Lastly, it has been 
suggested that the synergy between Gram-negative endotoxins and SAgs contributes to TSS lethality 
through TNF, as in vitro SAg-MHC II interaction and IFN- secreted by SAg-activated T cells induced 
an increase in the expression of TLR4, the cell receptor of LPS [55]. In the same way, LPS enhanced 
MHC II expression on APC [56]. 
3.3. Noninfectious Disease 
Several reports have described V-specific enrichments of T cells in different diseases, such as 
Kawasaki´ s disease and autoimmune diseases, so it has been proposed that SAgs might also contribute 
to the pathogenesis of noninfectious diseases through activation of T-cells specific for self-antigens. 
Kawasaki´ s disease is an acute febrile disease in children that resembles TSS, although the etiological 
agent remains unknown [57]. Most of the patients with this disease are colonized with  S. aureus 
carrying the tst gene and exhibit selective expansion of a V subset of T cells. Moreover, some 
patients increase their levels of IgM antibodies against SAg in the weeks following diagnosis with 
KD [58,59].  It  has  been  also  reported  a  selective  expansion  of  V  subsets  of synovial T cells  in 
arthritis [60] and in the pancreas of insulin-dependent diabetes mellitus [61]. Recently, it has also been 
postulated that SAgs could play a role in skin and airway allergies, such as atopic dermatitis, as IgE 
antibodies directed against SEA and SEB were detectable in these patients, and their levels were 
associated with the disease, suggesting that SAgs could function as conventional allergens [62]. 
4. Enterotoxin’s Superantigenic Activity 
The term superantigen was coined by John Kappler in 1989 [63] to denote the ability to stimulate 
large numbers of T cells, although this was an immunologist’s redefinition of a group of toxins that 
had been studied for many years prior as staphylococcal enterotoxins (SE) that caused food poisoning 
and  toxic  shock  and  the  streptococcal  pyrogenic  exotoxins  (SPEs),  agents  causing  scarlet  fever, 
pyrogenicity, and streptococcal TSS (STSS). Potent in vitro lymphocyte proliferation was a common 
feature of all the purified SEs, SPEs, and TSST-1. In a series of independent studies, the SE and SPEs 
were found to share two common functions: the ability to bind as whole molecules directly to MHC 
class II [64,65] and also to the TCR -chain [66] outside the normal antigen-binding interface that 
governed peptide MHC recognition [67]. Charles Janeway [68] first suggested that the SEs and the 
determinants encoded by the Mls (Mouse lymphocyte stimulating) system might act by cross-linking Toxins 2010, 2                                 
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the MHC class II and TCR V domain. Perhaps the most significant discovery in recent years has been 
the finding that SAgs belong to a much larger family that includes the staphylococcal superantigen-
like proteins (SSLs). These are built from the same two polypeptide domains but display a different set 
of anti-immune functions targeting the innate response. Together the SAgs and the SSLs reveal how a 
simple  protein  has  been  repeatedly  modified  to  produce  an  armamentarium  of  immune  defense 
molecules. 
At present, 20 serologically distinct staphylococcal SAgs have been described, comprising TSS 
toxin-1 (TSST-1), the SEs A-E, G-J, and the staphylococcal enterotoxin-like toxins (SEl) K-R and U, 
and  the  recently  identified  SEl-U2  and  SEl-V  [69].  Not  all  SAgs  are  enterotoxic  and  a  new 
nomenclature was introduced in 2004 to distinguish those with proven emetic activity (SEs) with those 
that remain unconfirmed (SEls) [30]. 
All the staphylococcal SAgs are potent T cells mitogens but exhibit different preferences for MHC 
class II alleles and also produce distinct TCRV profiles. This suggests that their diversity has been 
driven by a need to stimulate as many different T cells as possible while retaining MHC and TCR as 
target molecules. Superantigens, as well as the other extracellular staphylococcal virulence factors, are 
accessory proteins, i.e they are not required for growth and multiplication of the organism, and are 
often  encoded  by  accessory  genetic  elements  such  as  prophages,  transposons,  plasmids,  and 
pathogenicity  islands  (PIs).  These  mobile  elements  are  not  uniformly  distributed  among  clinical 
isolates and there are significant variations in these regions between different strains, most likely due 
to horizontal transfer [70]. 
The three dimensional structures of 10 staphylococcal and seven streptococcal SAgs have been 
solved by crystallography. All the structures reveal compact two domain globular proteins that range 
in size from 20 to 28 kDa. The N-terminal extension contributes substantially to the TCR-binding site 
that is formed as a shallow depression between the two protein domains. The SAgs are noted for their 
impressive  stability  to  denaturing conditions  such  as  heat and  acid and  as  a  consequence are  not 
completely destroyed by mild cooking of food, hence their potency in food poisoning. 
The notion that SAgs simultaneously bind MHC class II and TCR is unrealistic. The superantigen 
must first bind to MHC class II to concentrate onto the surface of the APC, making use of the adhesion 
and accessory molecules that form the immunological synapse. At some early point after APC binding, 
the surface concentration is sufficient to successively engage and cross-link multiple TCR molecules, 
resulting  in  strong  TCR  signaling,  activation,  and  rapid  cytokine  production.  The  affinity  of  SAgs 
towards MHC class II molecules is thus typically 10 to 100-fold higher than its affinities towards TCR. 
Those SAg/TCR solution interactions that have been quantified typically exhibit the same affinity and 
binding rates as those measured for TCR/peptide MHC interactions [71]. Based on crystallographic 
data  of  SAgs  complexed  with  MHC  class  II,  the  interaction  of  SAgs  with  MHC  class  II  can  be 
classified into 4 groups: (i) binding to MHC class II -chain entirely peripheral to the bound antigen 
peptide (peptide-independent binding), e.g., HLA-DR/SEB [72]; (ii) binding to MHC class II -chain 
and  extension  over  the  bound  peptide  (peptide-dependent  binding),  e.g.,  HLA-DR/TSST-1  [73]; 
(iii) zinc-mediated  binding  to  MHC  class  II  -chain  and  extension  over  the  bound  peptide  
(peptide-dependent binding), e.g., HLA-DR2/SPEC [74], HLA-DR1/SEH [75], HLA-DR1/SEI [76]; 
and  (iv) SAgs  that  combine  both  (i)  and  (ii)  binding  modes  such  as  SEA  to  cross-link  MHC  
class II [77,78]. Toxins 2010, 2                                 
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On the other hand, SAgs interact with TCR molecules by binding primarily to the variable region of 
the -chain (V-domain), resulting in oligoclonal stimulation of a defined T-cell repertoire, potentially 
activating more than 20% of all T cells. Crystal structures of SAgs in complex with V domains have 
revealed structurally diverse interactions, although binding to the TCRV CDR2 loop seems to be a 
requirement for all bacterial SAgs, whereas binding to other V domain regions appears to result in 
V domain specificity and crossreactivity of SAgs [71]. 
Attempts  to  separate  the  enterotoxin  activity  from  the  SAg  activity  have  yielded  inconclusive 
results. Nevertheless, a high correlation exists between these activities since, in most cases, genetic 
mutation resulting in a loss of superantigen activity results also in a loss of emetic activity. A highly 
flexible disulfide loop within the N-terminal domain has been implicated with the emetic activity but 
does not appear to be an absolute requirement [43]. It has also been suggested that the production of 
monocyte chemoattractant protein-1 (MCP-1) by intestinal myofibroblasts (IMFs) might play a role in 
SEA  food  poisoning  [79,80].  Cultured  human  IMFs  were  able  to  bind  SEA  in  an  MHC  class  
II-dependent fashion, resulting in increased release of MCP-1 and the consequential production of IL-6 
and IL-8. However, this mechanism fails to explain the emetic activity of other SEs, as it depended on 
the cross-linking of MHC class II molecules on IMFs by SEA, whereas incubation with SEB did not 
trigger a response. Hu et al. [81] postulated SEA-induced emesis through rapid serotonin release and 
showed in an animal model that SEA induces 5-hydroxytryptamine (5-HT) in the intestine, rather than 
in the brain. Receptors on vagal afferent neurons are essential for SEA-triggered emesis. 
The most likely role of SAgs is during the early stages of infection when the very low levels of SAg 
activate only local T cells. At this stage, the host response to S. aureus or S. pyogenes infection is entirely 
dependent on myeloid cells such as neutrophils and macrophages that are rapidly drawn to and engulf the 
invading  bacteria,  triggered  by  inflammatory  mediators  and  Fc  receptor  and  complement-mediated 
mechanisms.  One  possible  advantage  of  T-cell  activation  at  the  infection  site  might  be  to  produce 
cytokines such as IL-2, IFN-, and TNF-that suppress local inflammation.  
5. Antibiotic Resistance in S. aureus Correlation to Enterotoxigenic Strains 
Food is an important factor for the transfer of antibiotic resistances. Such transfer can occur by 
means of antibiotic residues in food, through the transfer of resistant food-borne pathogens or through 
the ingestion of resistant strains of the original food microflora and resistance transfer to pathogenic 
microorganisms [1,82]. S. aureus strains are known to be frequently resistant to antibiotic therapy due 
to  their  capacity  to  produce  an  exopolysaccharide  barrier  and  because  of  their  location  within 
microabscesses, which limit the action of drugs [83]. 
As previously related, it is well known that determinants of resistance to antibiotics and other toxic 
substances in staphylococci, as in other pathogens, are largely carried by accessory genetic elements, 
especially plasmids, transposons and their relatives. A particularly important resistance determinant in 
staphylococci is that for methicillin and other lactamase resistant -lactam compounds, giving rise to 
the notorious MRSA acronym. Although it has been clear for some time that a novel penicillin-binding 
protein, PBP2a [84,85], is responsible for this resistance, and that the PBP2a gene is not native to 
S. aureus,  there  has  been  considerable  uncertainty  regarding  the  nature  of  the  accessory  genetic 
elements that carry it. These were thought at one time to be plasmids or transposons [86], but have Toxins 2010, 2                                 
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recently been shown definitively to be a family of large chromosomal insertions that belong to the 
general category of chromosomal islands [87] and are appropriately regarded as resistance islands. 
The  staphylococcal  pathogenicity  islands  (SaPIs)  and  staphylococcal  chromosome  cassette 
methicillin-resistance islands (SCCmecs) represent two well-defined classes of novel mobile elements 
that  are  presumably  responsible  for  the  horizontal  transmission  of  SAg  and  certain  resistance 
determinants. It seems remarkable that the SaPIs carry only SAg determinants and the SCCmecs carry 
only resistance determinants. 
Several reports have recently analyzed the prevalence of enterotoxin genes in methicillin-resistant 
and  methicillin-susceptible  (MSSA)  isolates  of  S.  aureus.  Sila  et  al.  [88]  found  7  genes  more 
frequently detected in MRSA isolates: sea, seb, sed, seg, sei, sej and eta, coding for the production of 
enterotoxins A, B, D, G, I, J and the exfoliative toxin A. On the other hand, the pvl, tst and sec genes 
for Panton-Valentine leukocidin, TSST-1 and enterotoxin C were most frequent in MSSA. Statistical 
analysis of the comparison of the prevalence of virulence factors in the two studied groups showed 
significant difference in detection of the seg and sei genes. The characterization by Pereira et al. [17] 
of different S. aureus isolates collected from different food origins showed that 38% of the studied 
strains were MRSA, and 19% of the tested isolates were both enterotoxigenic and oxacillin positives. 
A correlation was observed between the antibiotic resistance profile of the strains isolated from cases 
of bovine mastitis and from the raw cow’s milk; in general, these specific isolates were demonstrated 
to be resistant to penicillin and ampicillin and more sensitive to the other antibiotics possibly as a 
result of treating mastitis cases with -lactams. In the case of isolates from fermented sausages, a 
higher overall resistance to antibiotics was observed (again possibly from using antibiotics as growth 
promoters in animal feed). Normanno et al. [89] studied 160 S. aureus strains from food of animal 
origin  products  in  Italy and  six  (3.75%)  harbored the  mecA gene. Each mecA positive strain was 
derived from a different food sample. In particular, four strains were from bovine milk, one strain from 
mozzarella cheese, and one from pecorino cheese. All the MRSA strains synthesized SEs. Two strains 
synthesized SEA and SED (33.3%), one strain SEC and SED (16.6%), two strains SED (33.3%) and 
one strain SEC (16.6%). Three MRSA strains (50%) belonged to the non-host-specific (NHS) biovar 
and  three  strains  (50%)  belonged  to  the  ovine  biovar.  However,  the  role  and  the  source  of  food 
contamination are still unclear since only few reports on the presence and possible origin of MRSA in 
foods are available. In his analysis of 1913 specimens from food-producing animals, including milk 
and meat of beef, pig and chicken origin, Lee [90] found 15 strains harboring the mecA gene. Most of 
the MRSA isolates were from milk and three from chicken. Lee concluded that contaminated foods of 
animal origin may represent a source of MRSA infection for humans. Recently, out of 444 samples of 
raw chicken meat examined by Kitai et al. [91], two (0.45%) harbored MRSA strains. One of the two 
strains isolated (one per positive sample) synthesized SEC and was thus capable of causing foodborne 
illness. Interestingly, these two MRSA strains belonged to the human biovar, suggesting that food 
handlers had been the source of contamination.  
Until now the correlation of antibiotic resistance and enterotoxigenicity of S. aureus has not been 
clearly supported by published results showing that food poisoning caused by MRSA is different of 
that caused by MSSA, except for the difference in prevalence of SE genes in these two populations. In 
turn the role of antibiotic resistance in the pathogenicity of SE-producing S. aureus has been revealed 
under  specific  conditions,  e.g.,  such  as  those  leading  to  AAD  (antibiotic  associated  diarrhea) Toxins 2010, 2                                 
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development. Alteration of gut  flora by antibiotic therapy seems to be important in regard to the 
expression of pathogenic properties of intestinal MRSA, frequently the only bacteria able to survive 
the  presence  of  antimicrobials.  Clinical  parameters  are  higher  in  ADD  patients  colonized  with 
enterotoxigenic MRSA than in those suffering from diarrhea not associated with MRSA or colonized 
with non-enterotoxigenic MRSA [92].  
6. Conclusions 
Staphylococcus  aureus  enterotoxins  function  both  as  potent  gastrointestinal  toxins  as  well  as 
superantigens that stimulate non-specific T-cell proliferation. Structurally, these two functions are located 
in two separate domains, so were initially considered to target different host tissues. An open question 
remains whether these separate functions are related. In recent years, staphylococcal enterotoxins with 
superantigenic activities have drawn more and more attention because of their anti-infection and anti-
tumor therapy potential. Superantigenic toxins with trace-level could significantly stimulate the immune 
system  in  primates  and  rodents  resulting  in  massive  cytokine  release.  To  decrease  the  toxicity  and 
enhance the superantigenic activities, some mutants of staphylococcal enterotoxins such as mSEA and 
mSEC2 have been constructed for tumor or infection therapy purposes. 
This question may also be related to how the toxins enter the body via the intestine. It has been 
found that epithelial cells are capable of a dose-dependent, facilitated transcytosis of SEs (tested on 
SEB and TSST-1) and that ingested SEB for example appears in the blood more readily than SEA. A 
working hypothesis is that the enterogenic activity may facilitate transcytosis, thus enabling the toxin 
to interact with T cells in the bloodstream, leading to superantigenic activity. More studies are needed 
to answer the questions regarding the activities of SEs as enterogenic and as superantigens. Moreover, 
understanding the mechanisms of subversion of the immune response by S. aureus will not only lead 
to new insights into the pathophysiology of infection and to new antimicrobial strategies, but could 
also provide the platform for the design of new therapies in inflammatory and autoimmune disorders. 
S. aureus is also well established as a clinical and epidemiological pathogen and the potentially 
pathogenic role of S. aureus as a food-borne pathogen should not be neglected. Antibiotic-resistant 
isolates might be transmitted to humans by the consumption of food products containing such resistant 
and  multiresistant  bacteria  and  the  use  of  antibiotics  as  growth  promoters  in  animal  husbandry, 
especially of those commonly used for both human and animal care, should be avoided. 
Recent findings highlight the high potential risk for consumers in the absence of strict hygienic and 
preventative  measures  to  avoid  the  presence  of  S.  aureus  isolates  and  SEs  production  in  foods, 
emphasizing  the need  for improved hygiene practices  during food processing  and  also during the 
distribution and consumption of the final food products. 
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